Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

US Patent 11673894 · Granted Jun 13, 2023

Estimated economic value: $39,837,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody binding to human CD38, preparation method thereof, and use thereof2025
Fluidized bed reactor, heat removal water pipe and application thereof in acrylo2025
Protective covers for electronic devices2025
Carboxamide compounds and uses thereof2025
Heterocyclic compounds as immunomodulators2025
Heterocyclic compounds as immunomodulators2025
Bicyclic amines as CDK2 inhibitors2025
Bicyclic amines as CDK2 inhibitors2025
Bicyclic amines as CDK2 inhibitors2025
Weakly-supervised object detection using one or more neural networks2025
Tricyclic compounds as inhibitors of KRAS2025
Tricyclic compounds as inhibitors of KRAS2025